Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biolex Therapeutics Inc.

www.biolex.com

Latest From Biolex Therapeutics Inc.

Dr Reddy's scoops OctoPlus to boost drug delivery capabilities

Dr Reddy's Laboratories is acquiring the Dutch service-based specialty pharmaceutical firm, OctoPlus, for €27.39 million, as part of efforts to expand its technology capabilities in drug delivery and the custom pharmaceutical services business.

Deals Shaping The Medical Industry, June 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Start-Ups Look For Places In Future HCV Combo Regimens

With more than 50 drugs in development for hepatitis C, what comes next after first-generation protease inhibitors and what opportunity might there be for small start-up firms in a space where so many Big Pharma and specialty pharma companies are active? Approvals of direct-acting antiviral therapies are just around the corner in hepatitis C, and smaller companies are looking to provide parts of the puzzle in next-generation drug cocktails that will tackle the growing disease. However, in order for small companies to succeed in this highly competitive space they'll need highly differentiated products. START-UP profiles AiCuris, Avila Therapeutics, Okairos, Viroblock and Zirus.
BioPharmaceutical

Recent Financings of Private Companies (09/2010)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Biolex Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Biolex Therapeutics Inc.
  • Senior Management
  • Jan Turek, Pres. & CEO
    Dale A Sander, SVP, Fin. & CFO
    David Spencer, PhD, SVP, R&D & COO
    Bipin Dalmia, PhD, SVP, Bus. Dev. & IP
  • Contact Info
  • Biolex Therapeutics Inc.
    Phone: (919) 542-9901
    158 Credle St.
    Pittsboro, NC 27312
    USA
UsernamePublicRestriction

Register